Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
24.12.25
/
50%
€23.80
Target price
24.12.26
€32.19
Performance (%)
22.69%
Price
13.08.26
€29.20
Summary
This prediction is currently active. The prediction currently has a performance of 22.69%. This prediction currently runs until 24.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 5.036% | 5.036% |
| iShares Core DAX® | 0.437% | 5.640% |
| iShares Nasdaq 100 | 1.057% | 0.282% |
| iShares Nikkei 225® | 1.769% | 0.406% |
| iShares S&P 500 | 0.368% | 1.920% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
31.07.26
31.07.26
€33.88
31.07.27
31.07.27
11.54%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.60
07.07.26
07.07.26
€35.85
07.07.27
07.07.27
-13.10%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.00
30.04.26
30.04.26
€30.85
30.04.27
30.04.27
21.67%
13.08.26
13.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.00
24.11.25
24.11.25
-
24.11.26
24.11.26
26.96%
13.08.26
13.08.26